TipRanks
Shattuck Labs (STTK)
NASDAQ:STTK
US Market
STTK
Shattuck Labs
RESEARCH TOOLSreports
Want to see STTK full AI Analyst Report?

Shattuck Labs (STTK) Stock News & Sentiment

269 Followers
Shattuck Labs Advances SL-325 Crohn’s Trial Toward a Key Value Milestone
Premium
Company Announcements
Shattuck Labs Advances SL-325 Crohn’s Trial Toward a Key Value Milestone
1M ago
STTK
Buy Rating Reaffirmed on Shattuck Labs as De-Risked SL-325 Strategy and Strong Cash Runway Support Unchanged $18 Price Target
Premium
Ratings
Buy Rating Reaffirmed on Shattuck Labs as De-Risked SL-325 Strategy and Strong Cash Runway Support Unchanged $18 Price Target
1M ago
STTK
Analyst Reaffirms Buy on Shattuck Labs, Maintains $17 Price Target on TL1A Pipeline Progress
Premium
Ratings
Analyst Reaffirms Buy on Shattuck Labs, Maintains $17 Price Target on TL1A Pipeline Progress
1M ago
STTK
Shattuck Labs Prices Upsized Public Equity and Warrant Offering
Premium
Company Announcements
Shattuck Labs Prices Upsized Public Equity and Warrant Offering
4M ago
8K
STTK
Shattuck Labs Reports Promising Phase 1 Data for SL-325
Premium
Company Announcements
Shattuck Labs Reports Promising Phase 1 Data for SL-325
4M ago
8K
STTK
Shattuck Labs Shareholders Approve Directors, Compensation, Governance Measures
Premium
Company Announcements
Shattuck Labs Shareholders Approve Directors, Compensation, Governance Measures
4M ago
8K
STTK
SL-325 Data Catalysts and Phase 2 Launch Plans Underpin Buy Rating on Shattuck Labs
Premium
Ratings
SL-325 Data Catalysts and Phase 2 Launch Plans Underpin Buy Rating on Shattuck Labs
5M ago
STTK
More STTK News >

STTK News on the Web

What Shattuck Labs Stock Topped the Market on Monday
The Motley Fool
Bullish
Shattuck Labs, Inc. (STTK) is a Great Momentum Stock: Should You Buy?
Zacks
Neutral
Wedbush Reaffirms Their Buy Rating on Shattuck Labs (STTK)
TipRanks News
Bullish
Shattuck Labs Incurs Higher Q2 Loss; To Advance SL-325 In Phase 2b For Crohn's Disease In Q3 '26
rttnews
Neutral
Why Shattuck Labs Stock Flew Nearly 5% Higher on Friday
The Motley Fool
Bullish
Insider Sell: Arundathy Pandite Sells 30,000 Shares of Shattuck Labs Inc (STTK)
GuruFocus News
Neutral
Orbimed Advisors LLC Increases Stake in Shattuck Labs Inc
GuruFocus News
Bullish
Top Biotech Gainers: SNSE Awaits Data In 2H, STTK To Begin Crohn's Trial In Q3, ALMS On Watch
rttnews
Bullish

News Score - Last 7 Days

Neutral
STTK
Sector Average
Media Buzz
This Week1 articles
Weekly Average0.75 articles
News Sentiment
This Week100%
Sector Average91%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is STTK’s Media Buzz Sentiment?
1 articles about STTK were published this week. In an average week, 0.75 articles are published.
    What is STTK’s weekly average amount of articles?
    In an average week, 0.75 articles about STTK are published.
      What is STTK’s News Sentiment?
      100% of articles about STTK were positive this week, compared to its sector average of 91%.
        Healthcare Stocks that are Trending in the News
        VRTXVertex Pharmaceuticals
        ATGGFActinogen Medical
        QGENQiagen
        ABBVAbbVie
        ANABAnaptysBio
        Showing the stocks with the most bullish news sentiment over the past week